Stopping a deadly virus in its tracks

January 31, 2014
Stopping a deadly virus in its tracks
Bats are a major source of lyssaviruses.

An international team of scientists, led by Dr Greg Moseley and Professor David Jans from the Monash School of Biomedical Sciences, has identified a novel vaccine strategy against lyssaviruses that cause rabies in animals and humans. Each year, over 60,000 people worldwide die from rabies following lyssavirus infections.

There are 15 known species of lyssaviruses, including Australian bat lyssavirus and , which are commonly transmitted by bats or dogs through bites or scratches. Infected animals and humans, if not treated rapidly with a series of injections of inactivated vaccines and expensive immunoglobulins, die in 100 per cent of cases. This is the highest fatality rate for any known infectious disease.

In a study published recently in the Journal of Infectious Diseases, scientists from Monash University; Institut Pasteur, Université Paris Diderot and CNRS, in France; and Gifu University, in Japan, have developed a mutated lyssavirus that cannot evade immune responses in the body, resulting in a weakened strain that is switched from a 100 per cent lethal pathogen to one that no longer causes disease in infected mice.

"The production of this new viral strain is a great first step towards making new live vaccines in the future," said Dr Moseley, the team leader from the Monash Department of Biochemistry and Molecular Biology.

"Live vaccines can be grown easily in large quantities, and delivered as a single oral dose, unlike existing 'killed' rabies vaccines that must be injected several times over an extended period, limiting their application in resource-poor countries."

In the research study, the researchers identified the region in a lyssavirus protein that inhibits immune responses.

"By making only two specific changes to the approximately 12,000 base pair viral genome, we have rendered the virus non-pathogenic," said lead author and Monash University PhD student Linda Wiltzer.

"We now plan to develop a candidate vaccine based on our attenuated virus, and test its safety and efficacy in mice."

If this approach is successful, Dr Moseley believes that this novel vaccine strategy may have widespread application for domestic animals and possibly humans who are exposed to bats or dogs that harbour lyssaviruses.

Since embarking on this vaccine research, Monash University has filed an Australian provisional patent application to facilitate future clinical development.

Explore further: Man's best friend: Common canine virus may lead to new vaccines for deadly human diseases

Related Stories

New rabies vaccine could reduce cost, risk

February 21, 2013

(Medical Xpress)—Researchers at the University of Georgia used a common dog disease-canine parainfluenza-to build a new vaccine to protect humans and animals from the rabies virus. Developers hope the new treatment will ...

Canine vaccinations effective deterrent to rabies in Africa

January 22, 2014

(Medical Xpress)—Yale School of Public Health researchers have found that annual canine vaccination campaigns not only stop the spread of rabies, a potentially deadly disease, but are cost-effective and may actually save ...

Recommended for you

Monkeys in Asia harbor virus from humans, other species

November 19, 2015

When it comes to spreading viruses, bats are thought to be among the worst. Now a new study of nearly 900 nonhuman primates in Bangladesh and Cambodia shows that macaques harbor more diverse astroviruses, which can cause ...

One-step test for hepatitis C virus infection developed

November 14, 2015

UC Irvine Health researchers have developed a cost-effective one-step test that screens, detects and confirms hepatitis C virus (HCV) infections. Dr. Ke-Qin Hu, director of hepatology services, will present findings at the ...

Computer model reveals deadly route of Ebola outbreak

November 10, 2015

Using a novel statistical model, a research team led by Columbia University's Mailman School of Public Health mapped the spread of the 2014-2015 Ebola outbreak in Sierra Leone, providing the most detailed picture to date ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.